Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
21.7%
% of XLV's 60 holdings also in GDOC
35.1%
% of GDOC's 39 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus GDOC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in GDOC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 12.3% | 9.7% | 9.7% |
|
ABBVIE INC | 6.9% | 6.4% | 6.4% |
|
UNITEDHEALTH GROUP INC | 9.0% | 5.2% | 5.2% |
|
ABBOTT LABORATORIES | 4.3% | 5.2% | 4.3% |
|
MERCK & CO. INC. | 4.3% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to GDOC
|
JOHNSON & JOHNSON | 7.5% |
|
UNITEDHEALTH GROUP INC | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
AMGEN INC | 3.1% |
|
PFIZER INC | 2.7% |
|
GILEAD SCIENCES INC | 2.6% |
|
ELI LILLY & CO | 2.6% |
|
VERTEX PHARMACEUTICALS INC | 2.4% |
|
STRYKER CORP | 2.4% |
|
BRISTOL-MYERS SQUIBB CO | 2.3% |
XLV Underweight Relative to GDOC
|
BOSTON SCIENTIFIC CORP | -5.6% |
 |
ASTRAZENECA PLC | -4.2% |
|
INSULET CORP | -4.1% |
 |
NOVO NORDISK A/S-B | -3.8% |
|
COOPER COS INC/THE | -3.4% |
|
BIOMARIN PHARMACEUTICAL INC | -3.3% |
 |
CSL LIMITED | -3.1% |
 |
LONZA GROUP AG-REG | -2.9% |
|
VEEVA SYSTEMS INC-CLASS A | -2.5% |
 |
HOYA CORP | -2.5% |